Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study

Neprilysin (NEP) is a neutral endopeptidase with diverse physiological roles in the body. NEP's role in degradation of diverse classes of peptides such as amyloid beta, natriuretic peptide, substance P, angiotensin, endothelins, etc., is associated with pathologies of alzheimer's, kidney a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Mol Struct
Asıl Yazarlar: Sankhe, Runali, Rathi, Ekta, Manandhar, Suman, Kumar, Avinash, Pai, Sreedhara Ranganath K, Kini, Suvarna G, Kishore, Anoop
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier B.V. 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7422802/
https://ncbi.nlm.nih.gov/pubmed/32834116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molstruc.2020.129073
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller